Position in LH
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$121,927,680
+$16,271,455 QoQ
Shares Held
435,456
+10.0% QoQ
Ownership
0.537%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#42
of 1,040 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $7,203,937,912 across 33 Diagnostics & Research names. LH ranks #16 (1.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,957,066 | $1,482,554,608 | |
| 2 | DHR |
Danaher Corp /De/
|
5,364,861 | $1,021,898,721 | |
| 3 | A |
Agilent Technologies, Inc.
|
4,707,720 | $625,326,445 | |
| 4 | GH |
Guardant Health, Inc.
|
3,775,895 | $566,497,524 | |
| 5 | NTRA |
Natera, Inc.
|
1,720,152 | $466,935,259 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
738,708 | $388,885,438 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,949,797 | $376,739,772 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
252,137 | $322,107,537 |
All Filings in LH
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $121,927,680 | 435,456 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $105,656,225 | 395,998 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $149,400,041 | 595,504 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $121,181,802 | 422,148 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $105,234,481 | 400,878 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $82,353,417 | 353,843 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $53,325,842 | 232,539 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $79,453,618 | 355,529 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||